Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroid-induced osteoporosis.

S F Hodgson1

  • 1Division of Endocrinology, Metabolism, and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Endocrinology and Metabolism Clinics of North America
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mediastinal parathyroid carcinoma.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2004
Same author

Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women.

Bone·2002
Same author

Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring.

Archives of surgery (Chicago, Ill. : 1960)·1999
Same author

Survival after the diagnosis of hyperparathyroidism: a population-based study.

The American journal of medicine·1998
Same author

The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.

Annals of internal medicine·1997
Same author

Three-year controlled, randomized trial of the effect of dose-specified loading and strengthening exercises on bone mineral density of spine and femur in nonathletic, physically active women.

Bone·1996
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Glucocorticoid-induced bone loss is a common issue causing fractures. Glucocorticoids affect calcium balance and bone formation, leading to bone loss, but effective treatments require further study.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Pharmacology

Background:

  • Glucocorticoid-induced bone loss is a significant clinical problem.
  • Bone loss can occur early in glucocorticoid therapy, linked to dose and osteoporosis risk factors.

Purpose of the Study:

  • To review the pathophysiology of glucocorticoid-induced bone loss.
  • To discuss potential prevention and treatment strategies.

Main Methods:

  • Literature review of existing studies on glucocorticoid effects on bone and calcium homeostasis.
  • Analysis of direct and indirect mechanisms contributing to osteopenia.

Main Results:

  • Glucocorticoids suppress intestinal calcium absorption and renal calcium reabsorption.

Related Experiment Videos

  • They also inhibit osteoblast function, leading to decreased bone formation.
  • Calcium and vitamin D supplementation, and bone resorption inhibitors are suggested, but require further evaluation.

    • Conclusions:

    • Glucocorticoids have direct and indirect effects on bone and calcium metabolism.
    • Secondary hyperparathyroidism exacerbates bone resorption.
    • Further prospective studies are needed to evaluate current and novel therapeutic approaches.